Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |